On Nov. 4, Crawford exercised options expiring in 2008 with an exercise price of $3.25 and sold the shares at prices of $33.75-$33.90. Monday’s filing lists another roughly 7.5 million options Crawford owns, including 1.25 million in a grantor retained annuity trust (GRAT).
Separately, analyst Steven Halper of Thomas Weisel upgraded Caremeark today from “peer perform” to “outperform.”
Shares of Caremark were up 14 cents to $34.29 in Monday afternoon trading. Their 52-week range $23.50-$35.31.
You must be logged in to comment. If you do not have an account, you can join our esteemed subscribers.